ARS Pharmaceuticals Inc
NASDAQ:SPRY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ARS Pharmaceuticals Inc
NASDAQ:SPRY
|
US |
Wall St Price Targets
SPRY Price Targets Summary
ARS Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
SPRY is 27.2 USD with a low forecast of 12.12 USD and a high forecast of 35.7 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SPRY's stock price target?
Price Target
27.2
USD
According to Wall Street analysts, the average 1-year price target for
SPRY is 27.2 USD with a low forecast of 12.12 USD and a high forecast of 35.7 USD.
What is the Revenue forecast for ARS Pharmaceuticals Inc?
Projected CAGR
39%
The compound annual growth rate for Revenue over the next 8 years is 39%.